Furthermore, these CXCR2−/− OT mice displayed a significant reduction in tumor burden at all time points (Figure 1d) and a significant extension in overall survival compared to CXCR2+/+ WT OT controls (Figure 1e). This evidence concerns the gene CXCR2 and neoplasm.